Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Pharm Res ; 12(7): 945-54, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7494814

ABSTRACT

PURPOSE: This review describes a conceptual approach to the characterization of pharmaceutical solids. METHODS: Four flow charts are presented: (1) polymorphs, (2) hydrates, (3) desolvated solvates, and (4) amorphous forms. RESULTS: These flow charts (decision trees) are suggested as tools to develop information on pharmaceutical solids for both scientific and regulatory purposes. CONCLUSIONS: It is hoped that this review will lead to a more direct approach to the characterization of pharmaceutical solids and ultimately to faster approval of regulatory documents containing information on pharmaceutical solids.


Subject(s)
Chemistry, Pharmaceutical/methods , Drug and Narcotic Control , Pharmaceutical Preparations/chemistry , Chemical Phenomena , Chemistry, Physical , Decision Trees
2.
J Aerosol Med ; 7(2): 119-34, 1994.
Article in English | MEDLINE | ID: mdl-10147277

ABSTRACT

Regulatory requirements for modifications to an approved innovator metered dose inhaler (pressurized MDI; USP nomenclature: inhalation aerosol) and for development of a new generic product are discussed. Although many of the requirements apply generally to MDI's, they are discussed with specific reference to albuterol. Changes to the container and closure system may impact on the dosimetry of the redesigned product, as well as upon toxicologic and chemistry, manufacturing and controls (CMC) concerns. Changes to the formulation, including the use of alternate propellants, may raise issues requiring both clinical and in vivo performance evaluation. In view of the level of interest of a number of firms in approval requirements for generic Albuterol Inhalation Aerosol products, the article discusses in considerable detail the CMC and bioequivalence requirements for a generic product. Similarities in the CMC requirements for innovator and generic products are evident. Three comparative in vivo bioequivalence tests, particle size distribution, spray pattern and plume geometry, and unit spray content, established by the Division of Bioequivalence are discussed. Similarities and differences in the in vivo requirements for innovator and generic products are evident. Differences are the result of U.S. statute, which requires safety and efficacy testing for a product approved under a new drug application (NDA), but documentation of bioequivalence for a product approved under an abbreviated new drug application (ANDA). The advantages and disadvantages of three pharmacodynamic study designs which have potential usefulness for documentation of in vivo bioequivalence are discussed.


Subject(s)
Bronchodilator Agents , Nebulizers and Vaporizers/standards , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/chemical synthesis , Bronchodilator Agents/pharmacokinetics , Bronchodilator Agents/standards , Drugs, Generic , Equipment Design , Humans , Legislation, Drug , Lung Diseases, Obstructive/drug therapy , Therapeutic Equivalency , United States , United States Food and Drug Administration
3.
J Chromatogr ; 231(1): 137-44, 1982 Aug 13.
Article in English | MEDLINE | ID: mdl-7119056

ABSTRACT

Ellipticine, a plant alkaloid effective against murine leukemias and solid tumors, is presently undergoing toxicological assessment prior to clinical trial. A rapid, sensitive, reversed-phase high-performance liquid chromatographic method employing an internal standard was developed for the detection of ellipticine and its principal metabolite 9-hydroxyellipticine after extraction from biological samples. The method was successfully applied to the quantitation of ellipticine in mouse blood and tissues after intravenous administration of ellipticine and to mouse blood levels of drug after oral administration. Similar success was achieved in determinations of ellipticine and 9-hydroxyellipticine in samples of spiked human blood and plasma. Mouse blood ellipticine levels monitored over 3 h after the intravenous administration of drug demonstrated a biphasic decline with a terminal half-life of 52 min.


Subject(s)
Alkaloids/analysis , Ellipticines/analysis , Animals , Brain Chemistry , Chromatography, High Pressure Liquid , Ellipticines/blood , Half-Life , Humans , Kidney/analysis , Liver/analysis , Mice , Myocardium/analysis , Spleen/analysis
4.
Am J Hosp Pharm ; 38(4): 483-6, 1981 Apr.
Article in English | MEDLINE | ID: mdl-6945043

ABSTRACT

The stabilities of doxorubicin hydrochloride, daunorubicin hydrochloride, zorubicin, and aclacinomycin A hydrochloride were studied in various infusion fluids at ambient temperature. Reversed-phase high-pressure liquid chromatographic procedures developed and used in these studies employed internal standards and readily separated each drug from its degradation products. Dilute solutions of the anthracyclines were prepared by appropriate dilutions of the reconstituted solutions of the formulated products with 5% Dextrose Injection, USP (D5W); 0.9% Sodium Chloride Injection, USP (NS); Lactated Ringer's Injection, USP (LR); and Normosol-R pH 7.4. The stability of the anthracyclines was dependent on the pH of the admixture solution which, in turn, was dependent on infusion fluid composition. Daunorubicin and aclacinomycin A exhibited acceptable stability (equal to 90% of the original concentration) in D5W, NS, and LR for more than 48 hours. Doxorubicin manifested similar stability in the first two fluids. Zorubicin showed similar stability only in Normosol-R pH 7.4 fluid for 22 hours.


Subject(s)
Antibiotics, Antineoplastic , Aclarubicin , Antibiotics, Antineoplastic/analysis , Chromatography, High Pressure Liquid , Daunorubicin , Doxorubicin , Drug Stability , Hydrogen-Ion Concentration , Infusions, Parenteral , Naphthacenes/analysis , Pharmacopoeias as Topic , United States
5.
J Pharm Sci ; 70(2): 159-62, 1981 Feb.
Article in English | MEDLINE | ID: mdl-7205219

ABSTRACT

The application of a rapid, selective, and sensitive reversed-phase high-performance liquid chromatographic method to the analysis of 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (I) and its degradation products is described. The method was used to study the kinetics of degradation of I over pharmaceutically useful pH ranges. The overall reaction rate followed pseudo-first-order kinetics. The pH-rate profile demonstrated optimal stability between pH 6.0 and 6.5. The degradation behavior suggests the existence of multiple pathways. The temperature dependence of th disappearance of I also was evaluated from the regression equation derived from the Arrhenius plot.


Subject(s)
Antineoplastic Agents , Aziridines , Azirines , Benzoquinones , Antineoplastic Agents/analysis , Aziridines/analysis , Azirines/analysis , Chromatography, High Pressure Liquid/methods , Drug Compounding , Drug Stability , Hydrogen-Ion Concentration , Kinetics , Solubility , Solutions , Temperature
6.
J Pharm Sci ; 70(2): 162-7, 1981 Feb.
Article in English | MEDLINE | ID: mdl-7205220

ABSTRACT

A direct high-performance liquid chromatographic (HPLC) method was applied to monitor 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (I) and its degradation products in pharmaceutical vehicles at 25 +/- 0.1 degrees. At the optimal pH for stability of I, an increase in buffer concentration [phosphate and tris(hydroxymethyl)-aminomethane] or ionic strength accelerated degradation. The reaction rate in the solutions studied followed pseudo-first-order kinetics. Degradation products were characterized by mass spectrometry after isolation by semipreparative HPLC. Different degradation pathways prevailed in acidic and basic media. The acid-catalyzed reaction resulted in consecutive aziridine ring opening, while the base-catalyzed reaction led to nucleophilic displacement of thie aziridine ring(s).


Subject(s)
Antineoplastic Agents/analysis , Aziridines/analysis , Azirines/analysis , Benzoquinones , Buffers , Chemical Phenomena , Chemistry , Chromatography, High Pressure Liquid/methods , Hydrolysis , Light , Mass Spectrometry/methods , Oxygen
9.
J Pharm Sci ; 69(6): 637-9, 1980 Jun.
Article in English | MEDLINE | ID: mdl-7205572

ABSTRACT

The application of a rapid, selective, and sensitive reversed-phase high-performance liquid chromatographic method to the separation of the hydrochloride salts of heroin (diacetylmorphine) and cocaine and their hydrolysis products is described. The method was used to study the stability of heroin and cocaine in Brompton mixtures in pharmaceutically useful pH range and vehicles at different temperatures. The pH range of optimal stability for both heroin and cocaine was 3.0-3.5. The disappearance of heroin and cocaine in Brompton mixtures followed pseudo-first-order kinetics in buffered solutions. Increased alcohol and decreased syrup concentrations diminished heroin hydrolysis but did not influence cocaine stability. Substitution of morphine for heroin in Brompton mixtures markedly increased the rate of cocaine hydrolysis.


Subject(s)
Cocaine/analysis , Heroin/analysis , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Drug Stability , Ethanol , Hydrolysis , Morphine/analysis
10.
J Pharm Sci ; 68(6): 728-32, 1979 Jun.
Article in English | MEDLINE | ID: mdl-458574

ABSTRACT

The apparent aqueous solubility of the water-insoluble cytotoxic agent, chartreusin, was increased at neutral pH in the presence of hydroxybenzoates. Water molecules play an important role in the chartreusin conformation. Studies included solubility and spectral examinations. The weakest and strongest interactants with chartreusin were sodium benzoate and sodium trihydroxybenzoate, respectively, while the effect of mono- and dihydroxybenzoates was intermediate. A plane-to-plane orientation of chartreusin and the ligand molecules brought together by electrostatic and hydrophobic interactions is postulated. The dramatic chartreusin aqueous solubility increase relative to its aglycone, chartarin, under similar conditions was best rationalized by micellization.


Subject(s)
Antibiotics, Antineoplastic , Glycosides , Hydroxybenzoates , Antibiotics, Antineoplastic/analysis , Chemical Phenomena , Chemistry, Pharmaceutical , Chemistry, Physical , Glycosides/analysis , Solubility , Solvents , Spectrophotometry , Spectrophotometry, Ultraviolet , Structure-Activity Relationship , Water
11.
J Chromatogr ; 171: 371-6, 1979 Apr 01.
Article in English | MEDLINE | ID: mdl-44709

ABSTRACT

The application of reversed-phase high-performance liquid chromatography to the measurement of 3,6-diacetylmorphine (DAM) hydrochloride and its degradation products is described. This method has been applied to study the kinetics of the DAM hydrolysis at 26 +/- 0.1 degrees and 48 +/- 0.1 degrees. The hydrolysis of DAM involved a two-step first-order sequential mechanism between pH 3 and 8.6. The first-order rate constants of each step at all pH levels have been determined. The pH rate profile was constructed from kinetic measurements and demonstrated that stability of DAM hydrochloride solutions was optimal at pH 4.3. This information is being applied to the development of parenteral dosage forms of DAM hydrochloride.


Subject(s)
Heroin/isolation & purification , Chromatography, High Pressure Liquid , Dosage Forms , Drug Stability , Humans , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Solutions/analysis
12.
J Med Chem ; 21(8): 833-7, 1978 Aug.
Article in English | MEDLINE | ID: mdl-99517

ABSTRACT

The antilipidemic properties of diethyl (4balpha,4calpha,9aalpha,4balpha)-3,6-dichlorocyclobutal[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate, herein termed dimer 8, were studied in sucrose-fed and in Triton-induced hyperlipidemic rats. Whereas clofibrate (0.4 mmol/kg) exhibited both anticholesterolemic and antitriglyceridemic activity, dimer 8 showed only antitriglyceridemic properties at the lower dose (0.2 mmol/kg) in sucrose-fed rats. Dimer 8 only lowered serum triglycerides levels in Triton WR-1339 hyperlipidemic rats, whereas clofibrate lowered both cholesterol and triglyceride levels. In the chronic sucrose-fed model, dimer 8 and clofibrate lowered hepatic HMG-CoA reducatase activity and produced significant elevations in several parameters of hepatic drug metabolism. No positive relationship between serum cholesterol lowering and reduction of hepatic HMG-CoA reductase activity was observed by these agents in sucrose-fed rats.


Subject(s)
Benzofurans/chemical synthesis , Clofibrate , Hypolipidemic Agents/chemical synthesis , Animals , Benzofurans/pharmacology , Cholesterol/blood , Cholesterol/metabolism , Clofibrate/pharmacology , Cyclobutanes/chemical synthesis , Cyclobutanes/pharmacology , Ethylmorphine-N-Demethylase/metabolism , Hydroxymethylglutaryl CoA Reductases/metabolism , Hyperlipidemias/blood , Hypolipidemic Agents/pharmacology , Liver/drug effects , Liver/enzymology , Liver/metabolism , Male , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Molecular Conformation , NADPH-Ferrihemoprotein Reductase/metabolism , Organ Size/drug effects , Rats , Sucrose/pharmacology , Triglycerides/blood , Triglycerides/metabolism
13.
Lipids ; 11(5): 384-91, 1976 May.
Article in English | MEDLINE | ID: mdl-1271976

ABSTRACT

The antilipidemic properties of certain benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a hyperlipidemic rat model are described. The hyperlipidemia was induced by intraperitoneal injection of Triton WR-1339. The results were analyzed in light of structural modifications as well as the lipid solubility of substituted compounds as assessed by a consideration of calculated log P values. Comparisons are made between the activity of these compounds and the activity of related cyclic analogs previously reported. Among the various compounds tested, only the 5-C1 and phenylsybstituted dihydrobenzofurans were selective against elevated serum cholesterol levels in this animal model. The data presented support the hypothesis that the cholesterol and triglyceride lowering activity of clofibrate related analogs in this animal model may be separated through a consideration of log P, conformational, and electronic changes. The proposal is advanced that relatively minor structural modification of clofibrate related analogs may lead to compounds which are not only selective in the Triton model but also to compounds which are likely to exert their effects by differing modes of action.


Subject(s)
Benzofurans/therapeutic use , Clofibrate/analogs & derivatives , Hypolipidemic Agents/therapeutic use , Animals , Benzofurans/chemical synthesis , Clofibrate/therapeutic use , Hyperlipidemias/chemically induced , Hyperlipidemias/drug therapy , Magnetic Resonance Spectroscopy , Polyethylene Glycols , Rats , Structure-Activity Relationship
14.
J Med Chem ; 18(10): 992-6, 1975 Oct.
Article in English | MEDLINE | ID: mdl-1159693

ABSTRACT

The synthesis and antilipidemic activity of 9-chloro-2,3-dihydro-5H-1,4-dioxepino[6,5-b]benzofuran (3), a novel enol lactone which is considerably more resistant to serum esterase hydrolysis than clofibrate (1), are discussed. Whereas both 3 and 1 reduced hypercholesterolemic and hypertriglyceridemic serum levels in the Triton WR-1339 induced hyperlipidemic Sprague-Dawley rat to normal, the hydrolysis product of 3, namely 5-chloro-3(2'-hydroxyethoxy)-2-benzofurancarboxylic acid (4), was found to be inactive. Further, 3 is comparable to the hydrolysis product of 1 when both were assessed for their ability to block norepinephrine (NE) induced lipolysis in vitro. 4 is inactive at comparable concentrations (5 times 10(-4)-10(-3) M). The antilipidemic action of 3 and 1 may, in part, be due to their ability to block NE-induced lipolysis.


Subject(s)
Benzofurans/chemical synthesis , Clofibrate , Hypolipidemic Agents/chemical synthesis , Adipose Tissue/cytology , Adipose Tissue/metabolism , Animals , Benzofurans/blood , Benzofurans/pharmacology , Cholesterol/blood , Clofibrate/blood , Depression, Chemical , Glycerol/metabolism , Hydrolysis , Hypolipidemic Agents/blood , Male , Mass Spectrometry , Norepinephrine/pharmacology , Oxepins/blood , Oxepins/chemical synthesis , Oxepins/pharmacology , Rats , Spectrophotometry, Infrared , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...